PRE LAB EXPERIMENT 2 and 3 Flashcards
(151 cards)
1
Q
the drawing of blood- is an integral part of medical laboratory practice
A
PHLEBOTOMY
2
Q
It is good to remember that no laboratory procedure will be any better than the quality of the specimen that is being tested.
A
PHLEBOTOMY
3
Q
Each step in the process affects the quality of the specimen and is this important for preventing laboratory error and patient injury.
A
PHLEBOTOMY
4
Q
For us medical technologist, this is the only time that we have
patient interaction.
A
PHLEBOTOMY
5
Q
For us medical technologist, this is the only time that we have
patient interaction.
A
PHLEBOTOMY
6
Q
affects the test result of the patient and the affects the quality of the specimen.
A
hemolysis
7
Q
– get blood from veins, suitable for serology
A
• Venipuncture
8
Q
– for micro sampling
A
• Capillary puncture
9
Q
– it is not used in serology
A
• Arterial puncture
10
Q
SOURCES BLOOD SPECIMEN
A
• Capillaries
• Arteries
• Veins
11
Q
(55% of total volume)
A
• Plasma
12
Q
o Fluid part
A
• Plasma
13
Q
(45% of total volume)
A
• Formed elements
14
Q
• Formed elements
A
o RBC
o WBC
o Platelets
15
Q
• Test tube containing
A
whole blood
16
Q
VENIPUNCTURE
A
• Open system
• Evacuated Tube system
• Winged Infusion set
17
Q
• utilization of hypodermic syringe, most used syringe is 10ml.
A
OPEN SYSTEM
18
Q
• Gauge used is
A
21-23; 25
19
Q
o note: the (?) the gauge the (?) the bore each gauge has corresponding hub color
A
higher
smaller
20
Q
• Length:
A
1 or 1.5 inches (1/2 to 1⁄4 in butterfly needle)
21
Q
• also called CLOSED SYSTEM
A
EVACUATED TUBE SYSTEM
22
Q
it is also used to collect multi samples or multi sampling
A
EVACUATED TUBE SYSTEM
23
Q
• this type of sampling is only used if the vein is superficial
A
WINGED INFUSION SET
24
Q
it is also known as BUTTERFLY SET
A
WINGED INFUSION SET
25
EQUIPMENTS
• Tourniquet
• Antiseptic solution
• Syringe and needle
• Evacuated tube set
• Butterfly infusion set
26
Antiseptic solution
o Isopropyl alcohol – iodine
o Chlorohexidine gluconate
o Benzalconium Cl / Zephiran
27
SITES OF COLLECTION
VEINS OF ANECUBITAL FOSSA ( 50-300 ANGLE)
28
VEINS OF ANECUBITAL FOSSA ( 50-300 ANGLE)
• Median cubital vein (1st choice)
• Cephalic vein (2nd)
• Basilic vein (3rd)
29
( 50-300 ANGLE)
VEINS OF ANECUBITAL FOSSA
30
(CAN BE LOWER THAN 50-300 ANGLE)
WRIST VEIN
31
Superficial vein of the dorsal hand
o cephalic vein, basilica vein, dorsal or metacarpal vein
32
WRIST VEINS
Superficial vein of the dorsal hand
VEINS ON DORSAL HAND
VEINS OF THE FOOT
33
Last resort for blood collection is from the (?) after the arm veins have been determine unsuitable.
VEINS OF THE FOOT
34
Always check with the hospital policy before this type of sampling is carried out.
VEINS OF THE FOOT
35
• Instituted by the Center of Disease Control in 1987
UNIVERSAL PRECAUTIONS 1987
36
all patients are considered to be possible carriers of blood-borne pathogens.
UNIVERSAL PRECAUTIONS 1987
37
wearing gloves when collecting or handling blood and body fluids contaminated with blood
UNIVERSAL PRECAUTIONS 1987
38
• The CDC excluded urine and body fluids that is not visibly contaminated by blood
UNIVERSAL PRECAUTIONS 1987
39
Although many specimens can contain a considerable amount of blood before it becomes visible.
UNIVERSAL PRECAUTIONS 1987
40
it only recommends wearing of gloves when there is a visual contamination of blood but if it is not visibly contaminated by blood, basically gloves are not recommended for use. This is one of the disadvantages
UNIVERSAL PRECAUTIONS 1987
41
• Guidelines are not limited to blood-borne pathogens
BODY SUBSTANCE ISOLATION
42
they consider all body fluids and moist body substances to be potentially infectious.
BODY SUBSTANCE ISOLATION
43
• (Unlike UP na kinoconsider lang as infectious ang body fluids that is contaminated by blood, BSI considers ALL body fluids).
BODY SUBSTANCE ISOLATION
44
• Personnel should wear gloves at all times when encountering
moist body substances.
BODY SUBSTANCE ISOLATION
45
• Major disadvantage: They do not recommend hand washing
following removal of gloves unless visual contamination is present.
BODY SUBSTANCE ISOLATION
46
• The CDC combined the major features of UP and BSI guidelines.
STANDARD PRECAUTIONS (1996)
47
• It is more complete and specific
STANDARD PRECAUTIONS (1996)
48
• We are now utilizing this one.
STANDARD PRECAUTIONS (1996)
49
• Addition of the following guidelines:
1. Hand washing
2. Gloves
3. Mask, eye protection and face shield
4. Gown
5. Patient care equipment
6. Environmental control
7. Linen
8. Occupational Health and Blood borne Pathogens
9. Patient placement
STANDARD PRECAUTIONS (1996)
50
WHAT TYPES OF EVACUATED TUBES ARE USED FOR
SEROLOGIC TESTING?
No additive (Red Top) and Serum Separator Tube are used for serologic testing
51
• This tube has no anticoagulant and it is used for blood clotting and the serum is separated by centrifugation.
NO ADDITIVE (RED TOP)
52
Wait for 30 minutes in order for the blood to clot and after that prepare the tube for serum.
NO ADDITIVE (RED TOP)
53
• These tubes contain clot activator and serum gel separator.
SERUM SEPARATOR TUBE (GOLD TOP) AND RED/GRAY MOTTLED TOP (TIGER TOP)
54
They contain serum gel at the bottom to separate the blood from serum upon centrifugation and used to form clot quickly and separate serum with gel at the bottom of the tube.
SERUM SEPARATOR TUBE (GOLD TOP) AND RED/GRAY MOTTLED TOP (TIGER TOP)
55
we don’t need to wait for 30 minutes. Direct to centrifugation.
SERUM SEPARATOR TUBE (GOLD TOP) AND RED/GRAY MOTTLED TOP (TIGER TOP)
56
NOTE:
A. No additive (red top)
B. Gold Top (SST)- We can see serum, gel, red cell (bottom of
the pic)
C. Tiger top (SST)
57
BLOOD SPILLS CAN ACCIDENTALLY HAPPEN IN THE LABORATORY. WHAT SHOULD BE DONE IN CASES OF SPILLAGE?
• Wipe immediately the blood spill.
58
The most commonly used disinfectant is a (?) prepared weekly and stored in a (?), not a glass, bottle.
1:10 dilution of sodium hypochlorite (household bleach)
plastic
59
The bleach should be allowed to air-dry on the (?) prior to removal.
a. Ibababad natin yung blood spill with the disinfectant, after na nag dry, iwipe natin siya ng cloth.
contaminated area
60
The National Committee for Clinical Laboratory Standards (NCCLS)states that a (?) can be used for routine cleaning
1:100 dilution
61
• If the patient is unconscious – take a look at the wristband, to confirm their identity
IN PATIENT
62
• Ask the watcher if the patient is unconscious
IN PATIENT
63
• If the patient is conscious, let them state their own name
IN PATIENT
64
• If the patient is a mute and has no wrist band, confirm it to the nurse station. Most of the time the beds have labels.
IN PATIENT
65
• Much easier, since they are conscious and ambulatory/mobile.
OUT PATIENT
66
• Always ask the patient to state his/her full name
OUT PATIENT
67
HOW IS PATIENT CARE SHOWN DURING PHLEBOTOMY?
• Not only done at the end of procedure but also when the patients (?) the phlebotomy area.
enters
68
• Introducing yourself to the patient
WELCOMING THE PATIENT
69
• Letting the patient know you're happy to see them
WELCOMING THE PATIENT
70
• Making the patient feel important
WELCOMING THE PATIENT
71
• You can also mention the test that will be performed
WELCOMING THE PATIENT
72
• Assessing the patient's comfort level quickly
PROVIDING PATIENT COMFORT
73
• Alleviating patient anxiety
PROVIDING PATIENT COMFORT
74
• Letting the patient know you care about their well being
PROVIDING PATIENT COMFORT
75
• Reassuring the patient they're in good hands
PROVIDING PATIENT COMFORT
76
LETTING THE PATIENT KNOW IT WAS A PLEASURE TO SEE THEM
77
• Talking with the patient about the procedure so they're kept informed and know what to expect
EFFECTIVE PATIENT COMMUNICATION
78
• Asking the patient if they've ever fainted during a blood draw
EFFECTIVE PATIENT COMMUNICATION
79
Asking for patient feedback during the procedure
EFFECTIVE PATIENT COMMUNICATION
80
• Thanking the patient for visiting the medical facility
AFTER PATIENT CARE
81
• After applying gauze, apply pressure
AFTER PATIENT CARE
82
• Puncture only the uppermost wall of the vein
HEMATOMA
83
• Remove the tourniquet before removing the needle
HEMATOMA
84
• Use the major superficial veins (preferred: median cubital
vein)
HEMATOMA
85
• Make sure the needle fully penetrates the upper most wall of
the vein. (Partial penetration may allow blood to leak into the
soft tissue surrounding the vein by way of the needle bevel)
HEMATOMA
86
• apply pressure to the venipuncture site
HEMATOMA
87
(WHICH CAN INTERFERE WITH MANY TESTS)
HEMOLYSIS
88
• Mix tubes with anticoagulant additives gently 5-10 times (inversions depend on the anticoagulant used. EDTA: 8 times ; Sodium citrate: 3-5 times)
HEMOLYSIS
89
• Avoid drawing blood from a hematoma
HEMOLYSIS
90
• Avoid drawing the plunger back too forcefully, if using a
needle and syringe, or too small a needle, and avoid frothing
of the sample.
HEMOLYSIS
91
• Make sure the venipuncture site is dry
HEMOLYSIS
92
• Avoid a probing, traumatic venipuncture
HEMOLYSIS
93
• Avoid prolonged tourniquet application (max of 2 minutes) or
fist clenching
HEMOLYSIS
94
o Fist clenching is not advised in terms of
venipuncture
95
o Fist clenching is advisable during
blood donation
96
• an increased concentration of larger molecules and formed elements in the blood
HEMOCONCENTRATION
97
• Prolonged tourniquest application (no more than 1 minute)
HEMOCONCENTRATION
98
• Massaging, squeezing, or probing a site
HEMOCONCENTRATION
99
• Long- term IV theraphy
HEMOCONCENTRATION
100
• Primary effect is hemoconcentration of non-filterable elements (i.e.proteins).
PROLONGED TOURNIQUET APPLICATION
101
The hydrostatic pressure causes some water ad filterable elements to leave the extracellular space.
PROLONGED TOURNIQUET APPLICATION
102
• Significant increases can be found in total protein, aspartate aminotransferase (AST), total lipids, cholesterol, iron
PROLONGED TOURNIQUET APPLICATION
103
• Affects packed cell volume and other cellular elements
PROLONGED TOURNIQUET APPLICATION
104
• Hemolysis may occur, with pseudohyperkalemia
PROLONGED TOURNIQUET APPLICATION
105
- false increase of potassium
Pseudohyperkalemia
106
• Preferred site:
antecubital fossa (median cubital vein)
107
• Median cubital vein (unavailable):
cephalic vein
108
• Least preferred area in the antecubital fossa:
basilic vein
109
• Antecubital fossa (unavailable): proceed to
superficial
veins of the dorsal hand
110
• Wrist vein (unavailable):
superficial veins of the foot
111
The last resort for blood collection is
• Superficial Veins of the foot
112
Always check with t5he hospital policy before this type of sampling is carried out
• Superficial Veins of the foot
113
place in an anticoagulated tube – after mixing it will be the
WHOLE BLOOD
114
anticoagulated – centrifuge – separate the supernatant and red cell
PLASMA
115
plain tube/red top with clot activator/ or with gel separator – centrifuge – separate supernatant and pack red cell
SERUM
116
• heat the serum at 56 degrees Celsius for 30 minutes
SERUM INACTIVATION
117
RED CELL SUSPENSION
• collect the pack red cell - washed with saline or the NSS
3x
118
concentration of red cell suspension
• 2-5%
119
• Desired red cell suspension (RCS) =
Washed packed red blood cell (WPRCB) volume x 100/Total volume (TV) of the RCS preparation
120
Total volume of RCS =
WPRBC + volume of diluent NSS added to prepare desired %RCS
121
• Liquid portion of unclotted blood
PLASMA
122
• Contains the fibrinogen group of coagulation factors
PLASMA
123
• Lighter yellow and little turbid
PLASMA
124
• Chemically does not contain much platelet derivatives
PLASMA
125
• Liquid portion of the clotted blood
SERUM
126
• Does not contain the fibrinogen group of coagulation factors
SERUM
127
• Darker yellow and clearer
SERUM
128
• Contains higher levels of platelet derivatives
SERUM
129
• Is a common reagent used for many serologic procedures
RED CELL SUSPENSION
130
• Provide the appropriate serum to allow for grading and
interpretation of test results
RED CELL SUSPENSION
131
• The concentration of RCS is 2-5%
RED CELL SUSPENSION
132
Since the antibodies are found in (?), it is the preferred sample to use in serologic testing.
serum
133
(?), also don’t have fibrinogen or other anticoagulant factors that may alter the results of the tests, while (?) that contains anticoagulant, is subject to affect the 50% of the total of the total laboratory turnaround.
Serum
plasma
134
is done to allow separation of the cells and clotting factors and to avoid the formation of fibrin clots while still maintaining proteins and other molecules that represent the whole-body system when centrifuged.
Complete clotting
135
After collection of the whole blood, it should be allowed to clot by living it undisturbed at room temperature. This is usually taking
15-30 minutes.
136
Remove the clot by centrifuging at (?) in a refrigerated centrifuge.
1,000-2,000 x g for 10 minutes
137
To prevent the formation of fibrin clots, since fibrin
clots may also cause a false positive reaction specially in terms of hemagglutination procedures
Complete clotting
138
DESCRIBE AND DISCUSS WHY THE FOLLOWING SAMPLES ARE NOT USED IN SEROLOGIC TESTING
HEMOLYZED SAMPLE
LIPEMIC SAMPLE
ICTERIC SAMPLE
139
once the red cells will lyze the hemoglobin will go out of the cell and because od that It cause non specific binding)
HEMOLYZED SAMPLE
140
• Serum samples containing more than (?) of hemoglobin can cause non-specific binding in serologic testing is not recommended for a serum sample containing more than this amount of hemoglobin.
100mg/dl
141
can interfere with measured analytes and chemical interactions.
LIPEMIC SAMPLE
142
This is especially important in electrophoretic methods.
LIPEMIC SAMPLE
143
can also non-specifically interfere in various immunoassays.
LIPEMIC SAMPLE
144
can interfere with antigen- antibody reaction by blocking binding sites on antibodies.
LIPEMIC SAMPLE
145
This can happen even when antibodies are bound to a solid surface.
LIPEMIC SAMPLE
146
Depending on the nature of the reaction, the interference can cause both, falsely elevated of falsely decreased result.
LIPEMIC SAMPLE
147
in serologic tests, some procedures require the use of
inactivated serum
148
Since Inactivation is the process that destroys complement activity, complement is known to interfere with the reactions certain syphilis tests and complement components.
inactivated serum
149
It can agglutinate latex particles and cause a false positive reaction in latex passive agglutination assays.
inactivated serum
150
Complement may also cause lysis of the indicator cells in hemagglutination assays
inactivated serum
151
wearing face shields when there is danger of blood splashing on mucous membranes and when disposing of all needles and sharp objects in puncture-resistant containers.
UNIVERSAL PRECAUTIONS 1987
